Vahid Entezari , MD

Post-doctoral Research Fellow

Phone: 617.667.4612

Fax:     617.667.7175

Email:  ventezar@bidmc.harvard.edu

Background

I am a graduate of Iran University of Medical Sciences (IUMS) with an MD degree. Soon afterward, I started working with Dr Shahram Latifzadeh, a Hemato-oncologist at the Cancer Institute of Iran. As a research fellow, I had daily contact with advanced cancer patients and became interested in skeletal metastasis and other cancer related bone diseases. I received the International Development and Education Award (IDEA) from the American Society of Clinical Oncology in 2005 to visit the center for sarcoma and bone oncology at the Dana Farber Cancer Institute as a traveling fellow. One year later, I joined the orthopedic biomechanics laboratory as a post-doctoral research fellow and started working on “Non-invasive computed tomography-based evaluation of changes in bone structural properties in patients undergoing anti-cancer treatment” with the support of Cancer Technology Transfer fellowship from the International Union against Cancer. My mentor is Brian D Snyder M.D. Ph.D. and I am a member of the team who works on clinical validation of CT-based structural rigidity analysis in predicting fracture risk and monitoring treatments’ effect in metastatic skeletal lesions. My clinical interests are in general orthopedic surgery and orthopedic oncology and my long-term goal is to become an orthopedic oncologist in a major academic center where I can practice both as a surgeon and as a clinician scientist.

Publication/Presentations

1. Latifzadeh SZ, Entezari V, Shashaani T, Jazebi M. Prevalence of Activated Protein C Resistance (APC-R) in patients with thromboembolic events: the first report from Iran [Abstract], Journal of Thrombosis and Haemostasis, 2003; 1 (1S): P0894.
2. Latifzadeh SZ, Entezari V. Effect of megestrol acetate, cyproheptadine, and their combination on appetite, body weight and quality of life (QOL) in cancer patients: A double-blind placebo-controlled clinical trial [Abstract]. Journal of Clinical Oncology, 2004; 22(14S):8141.
3. Entezari V, Latifzadeh SZ, Akhavanfard S. Metastatic Colorectal Cancer (MCC) and Irinotecan (IRI), 5-Flourouracil (5FU), Leukovorin (LV) three-day chemotherapy [Abstract]. Journal of Clinical Oncology, 2005; 23(16S):3729.
4. Latifzadeh SZ, Entezari V, Akhavanfard S. Docetaxel, Cisplatin, 5-Flourouracil x 3 days (DCF3) compared to Docetaxel, Cisplatin, 5-Flourouracil x 5 days (DCF5) chemotherapy for patients with metastatic or locally advanced unresectable gastric carcinoma (MGC). Journal of Clinical Oncology, 2005; 23(16S):4258.
5. Latifzadeh SZ, Riahi , Entezari V. Working Formulation (WF) and Revised European-American classification of Lymphoma (REAL): inter-observer agreement in conflicting lymphoma cases [Abstract]. Journal of Clinical Oncology, 2006; 24(18S):17567.
6. Latifzadeh SZ, Entezari V. Chronic Refractory Idiopathic Thrombocytopenic Purpura (ITP) and Anti-CD20 Monoclonal Antibody: a case report and brief review. Clinical and Applied Thrombosis and Hemostasis. 2006; 12 (4): 489-492.
7. Latifzadeh SZ, Salimi M, Naghnaeian M, Entezari V. Dose-dense (DD) two-weekly docetaxel / doxorubicin / cyclophosphamide (TAC) with G-CSF support compared to standard adjuvant TAC in breast cancer patients. Journal of Clinical Oncology, 2007; 25(18S):11052.
8. Mehta HP, Snyder BD, Jackson AC, Baldassarri SR, Hayward MJ, Giuffrida MJ, Entezari V, Wilson JM. How Does VEPTR Affect Pulmonary Function? An in vivo Assessment Using the Rabbit Scoliosis Model [oral presentation]. 1st International Congress on Early Onset Scoliosis and Growing Spin, Nov 2007 - Madrid , Spain [Winner of the award for the best paper in the conference]
9. Bansal PN, Joshi NS, Entezari V, Grinstaff MW, Snyder BD. Quantitative CT arthrography can measure the glycosaminoglycan (GAG) content of articular cartilage in intact and degraded joints. Trans. Orthop. Res. Soc., 2008.
10. Bansal PN, Joshi NS, Entezari V, Grinstaff MW, Snyder BD. Quantitative CT arthrography can predict the glycosaminoglycan (GAG) content and biomechanical properties of articular cartilage. 2008 Pediatric Orthopedic Society of North America (POSNA) annual meeting - Albuquerque , New Mexico .